Patent ID: 8518978

Claim:
A method for reducing or delaying the onset of a clinical marker or symptom of restenosis or treating restenosis comprising: administering to a subject in need thereof a pharmaceutical composition which comprises a therapeutically effective amount of a compound of Formula 1, or a pharmaceutically acceptable salt thereof: wherein, R 1 is furanyl or thienyl, wherein R 1 is optionally substituted with one or more substituents independently selected from the group consisting of acyl, amino, carboalkoxy, carboxy, carboxyamino, —O—(C═O)—NH 2 , cyano, halo, hydroxy, nitro, alkyl, cycloalkyl, aryl, alkoxy, aryloxy, sulfoxy and guanido, m is 2 or 3, A is a bond, —O—, —S—, —SO— or —SO 2 —, and R 2 is imidazolyl, pyrazolyl, triazolyl, tetrazolyl or pyridinyl, wherein R 2 is optionally substituted with one or more substituents independently selected from the group consisting of acyl, amino, carboalkoxy, carboxy, carboxyamino, —O—(C═O)—NH 2 , cyano, halo, hydroxy, nitro, alkyl, cycloalkyl, aryl, alkoxy, aryloxy, sulfoxy and guanido.